Medical devices, healthcare technology and the business of care
DEVICE CATEGORY · PWD

Flow Cytometric Test System For Hematopoietic Neoplasms

Reagents intended for in vitro diagnostic use as a panel for qualitative identification of cell populations by multiparameter immunophenotyping on a flow cytometer. These reagents are used as an aid in the differential diagnosis of hematologically abnormal patients having, or suspected of having the following hematopoietic neoplasms: chronic leukemia, acute leukemia, non-Hodgkin's lymphoma, myeloma, myelodysplastic syndrome (MDS), and/or myeloproliferative neoplasms (MPN)

Product / regulatory recordCompanyPathwayDecision dateSource
Bd Biosciences510(k) clearanceOct 20, 2026FDA
Source information

Follow the FDA links to view the original records.

All device categories